Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Deupirfenidone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 99,600Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PureTech Unveils Strategy & Ph 2b Data for Deupirfenidone in IPF
    PureTech Unveils Strategy & Ph 2b Data for Deupirfenidone in IPF

    21 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250821614975/en/PureTech-Showcases-Differentiated-Development-Strategy-Including-New-Patient-Preference-Insights-and-Spotlights-Phase-2b-Data-Positioning-Deupirfenidone-as-a-Potential-New-Standard-of-Care-in-IPF

    BUSINESSWIRE
    21 Aug 2025
    Share Share
    PureTech Creates Celea to Develop Promising Lung Disease Drug
    PureTech Creates Celea to Develop Promising Lung Disease Drug

    13 Aug 2025

    // FIERCE PHARMA

    https://www.fiercebiotech.com/biotech/puretech-launches-celea-therapeutics-develop-highly-touted-lung-disease-candidate

    FIERCE PHARMA
    13 Aug 2025
    Share Share
    PureTech's deupirfenidone shows durable effect in IPF study
    PureTech's deupirfenidone shows durable effect in IPF study

    21 May 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/puretech-shows-durability-pulmonary-fibrosis-candidate-deupirfenidone

    FIERCE BIOTECH
    21 May 2025
    Share Share
    PureTech to Present Phase 2b ELEVATE IPF Trial Results at ATS Conf
    PureTech to Present Phase 2b ELEVATE IPF Trial Results at ATS Conf

    01 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250501295892/en/PureTech-to-Present-Results-from-Phase-2b-ELEVATE-IPF-Trial-of-Deupirfenidone-LYT-100-at-the-American-Thoracic-Society-International-Conference

    BUSINESSWIRE
    01 May 2025
    Share Share
    PureTech’s LYT-100 Slows Lung Decline in IPF, Key Endpoints
    PureTech’s LYT-100 Slows Lung Decline in IPF, Key Endpoints

    16 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241215811061/en

    BUSINESSWIRE
    16 Dec 2024
    Share Share
    PureTech Presents IPF Research And LYT-100 Analysis At CHEST
    PureTech Presents IPF Research And LYT-100 Analysis At CHEST

    08 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241008271143/en

    BUSINESSWIRE
    08 Oct 2024
    Share Share